Furthermore, down-regulated CHFR inhibited paclitaxel sensitivity, elevated Aurora A expression, but did not affect DNMT1 and UBC13 in ovarian cancer cells (Fig. 5g, h), and vice versa (Fig. 5i, j). This evidence concerns the gene UBE2N and ovarian carcinoma.